3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
55
Colonic Neoplasms
22
Adenoma
16
Colonic Polyps
13
Polyps
7
Colorectal Neoplasms, Hereditary Nonpolyposis
6
Neoplasms
5
Adenomatous Polyps
5
Rectal Neoplasms
4
Pain
4
Disease
4
Colitis, Ulcerative
2
Anus Neoplasms
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Recurrence
1
Personal Satisfaction
1
Patient Satisfaction
1
Pathologic Complete Response
1
Lymphoma, Mantle-Cell
1
Li-Fraumeni Syndrome
1
Irritable Bowel Syndrome
1
Intestinal Neoplasms
1
Inflammatory Bowel Diseases
1
Hyperplasia
1
Hamartoma Syndrome, Multiple
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Diverticulitis, Colonic
1
Diverticulitis
1
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Epirubicin
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Observation
2
Monatide (IMS 3015)
2
Metformin
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pathologic Complete Response
×
Colonoscopy
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled